QRISK3与SCORE2对系统性红斑狼疮患者颈动脉斑块的预测可靠性相当
本研究在365例系统性红斑狼疮(SLE)患者中评估颈动脉超声所见的亚临床动脉粥样硬化,计算QRISK3与SCORE2评分,比较两者识别颈动脉斑块的预测效能。结果显示QRISK3的AUC为0.770(95%CI 0.720,0.821),SCORE2的AUC为0.800(95%CI 0.753,0.843),两者差异无统计学意义(P=0.070);两评分联合的判别能力显著优于单用QRISK3(P=0.034),但与单用SCORE2相比无显著差异(P=0.71)。作者认为QRISK3与SCORE2对SLE患者颈动脉斑块的预测可靠性相当,单用SCORE2即可识别心血管事件高危的SLE患者。
要点
- QRISK3与SCORE2对SLE患者颈动脉斑块的预测效能相似,AUC分别为0.770与0.800。
- 两评分联合的判别能力显著优于单用QRISK3(P=0.034),但与单用SCORE2无显著差异(P=0.71)。
- 作者认为单用SCORE2、无需额外工具即可识别心血管事件高危的SLE患者。
核心结论
- QRISK3与SCORE2对SLE患者颈动脉斑块的预测可靠性相当。
- 两评分联合的判别能力显著优于单用QRISK3,但与单用SCORE2相比无显著差异。
- 作者认为单用SCORE2、无需额外工具即可识别心血管事件高危的SLE患者。
研究设计与样本
- 研究纳入365例SLE患者,采用颈动脉超声评估亚临床动脉粥样硬化。
- 计算QRISK3与SCORE2评分,将评分作为连续变量与分类变量、分别及联合分析其与颈动脉斑块的关系。
- 采用逻辑回归与受试者工作特征曲线下面积(AUC)分析评估预测准确性。
主要发现
- QRISK3预测颈动脉斑块的AUC为0.770(95%CI 0.720,0.821)。
- SCORE2预测颈动脉斑块的AUC为0.800(95%CI 0.753,0.843)。
- QRISK3与SCORE2的AUC差异无统计学意义(P=0.070)。
- 两评分联合的判别能力显著优于单用QRISK3(P=0.034),但与单用SCORE2相比无显著差异(P=0.71)。
关键数值与推荐
- QRISK3预测颈动脉斑块的AUC为0.770(95%CI 0.720,0.821)。
- SCORE2预测颈动脉斑块的AUC为0.800(95%CI 0.753,0.843)。
- QRISK3与SCORE2的AUC差异P=0.070。
- 两评分联合与单用QRISK3比较P=0.034,与单用SCORE2比较P=0.71。
临床怎么用
- 作者认为单用SCORE2、无需额外工具即可识别心血管事件高危的SLE患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cardiovascular (CV) disease is the leading cause of death among patients with SLE. This study aimed to compare the performance of QRESEARCH risk estimator version 3 (QRISK3) and the Systematic Coronary Risk Evaluation-2 (SCORE2) scores to identify SLE patients at high risk of CV events, as indicated by the presence of carotid plaques. METHODS: Subclinical atherosclerosis was evaluated using carotid US in 365 SLE patients. QRISK3 and SCORE2 were calculated. The relationship between these scores and the presence of carotid plaques was analysed by treating the scores as continuous and categorical variables, as well as separately and in combination. Logistic regression and area under the receiver operating characteristic curve (AUC) analyses were used to assess their predictive accuracy. RESULTS: The discriminatory capacity of QRISK3, with an AUC of 0.770 (95% CI 0.720, 0.821), and SCORE2, with an AUC of 0.800 (95% CI 0.753, 0.843), for carotid plaque was similar, with no statistically significant difference (P = 0.070). However, when examining the association of both calculators considered continuously and together with their interaction, the discriminatory capacity of this combination was significantly greater than that of QRISK3 alone (P = 0.034) but did not differ from SCORE2 (P = 0.71). CONCLUSION: QRISK3 and SCORE2 are equally reliable predictors of carotid plaques in SLE patients. The combination of both calculators offers significantly better discrimination than QRISK3 alone but shows no significant difference when compared with SCORE2 alone. Therefore, SCORE2 alone, without the need for additional tools, can be used to identify patients with SLE who are at high risk of CV events.
引用
- Ferraz-Amaro I, Heras-Recuero E, Quevedo-Abeledo JC, et al. QRISK3 and SCORE2 are equally reliable predictors of carotid plaques in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2025. PMID: 39495166. doi:10.1093/rheumatology/keae611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。